Mayasi Yunis, Helenius Johanna, Goddeau Richard P, Moonis Majaz, Henninger Nils
Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts.
Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts; Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts.
J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2373-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.036. Epub 2016 Jun 14.
Delayed thrombolysis adversely impacts functional outcome after stroke. Therefore, great efforts are undertaken to reduce delay in patient presentation and initiate treatment as quickly as possible. However, little is known regarding the impact of time to presentation (TTP) on outcome in patients who are ineligible for acute stroke therapy. Thus, we sought to determine whether the TTP is associated with the 90-day outcome irrespective of eligibility for acute recanalization therapy.
We retrospectively analyzed 258 consecutive acute ischemic stroke patients evaluated between January 2013 and February 2014. Multivariable logistic regression was used to determine whether a greater TTP is independently associated with a poor 90-day outcome defined as a modified Rankin scale (mRS) score of 3-6.
In the unadjusted analyses, the TTP was inversely correlated with transfer from an acute facility (r = -.126, P = .043), cardioembolic stroke etiology (r = -.146, P = .019), and acute recanalization therapy (r = .-412, P < .001). Conversely, a longer TTP was correlated with a worse 90-day mRS score (r = .127, P = .045). After adjustment, the TTP (P = .019), age (P < .001), female sex (P = .001), National Institutes of Health Stroke Scale score (P < .001), preadmission mRS score (P = .001), atrial fibrillation (P < .001), and infarct volume (P < .001) were independently associated with a poor 90-day outcome. Importantly, a longer TTP (odds ratio 1.016, 95% confidence interval 1.001-1.032, P = .036) remained independently associated with the 90-day outcome when we restricted the analyses to patients ineligible for acute intravenous and endovascular recanalization therapies.
Each hour delay in the TTP decreased chances for good outcome by approximately 2% independent of patient eligibility for acute recanalization therapies.
延迟溶栓会对卒中后的功能结局产生不利影响。因此,人们付出了巨大努力来减少患者就诊延迟并尽快开始治疗。然而,对于不符合急性卒中治疗条件的患者,就诊时间(TTP)对结局的影响却知之甚少。因此,我们试图确定TTP是否与90天结局相关,而不考虑是否符合急性再通治疗的条件。
我们回顾性分析了2013年1月至2014年2月期间连续评估的258例急性缺血性卒中患者。采用多变量逻辑回归分析来确定较长的TTP是否与90天不良结局独立相关,90天不良结局定义为改良Rankin量表(mRS)评分为3 - 6分。
在未校正分析中,TTP与从急性医疗机构转诊呈负相关(r = -0.126,P = 0.043)、心源性栓塞性卒中病因呈负相关(r = -0.146,P = 0.019)以及急性再通治疗呈负相关(r = -0.412,P < 0.001)。相反,较长的TTP与更差的90天mRS评分相关(r = 0.127,P = 0.045)。校正后,TTP(P = 0.019)、年龄(P < 0.001)、女性(P = 0.001)、美国国立卫生研究院卒中量表评分(P < 0.001)、入院前mRS评分(P = 0.001)、心房颤动(P < 0.001)和梗死体积(P < 0.001)与90天不良结局独立相关。重要的是,当我们将分析限制在不符合急性静脉和血管内再通治疗条件的患者时,较长的TTP(比值比1.016,95%置信区间1.001 - 1.0